Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

Autor: Morrow, Richard L, Mintzes, Barbara, Souverein, Patrick C, De Bruin, Marie L, Roughead, Elizabeth Ellen, Lexchin, Joel, Kemp-Casey, Anna, Puil, Lorri, Sketris, Ingrid, Mangin, Dee, Hallgreen, Christine E, Pearson, Sallie-Anne, Lopert, Ruth, Bero, Lisa, Ofori-Asenso, Richard, Gnjidic, Danijela, Sarpatwari, Ameet, Perry, Lucy T, Dormuth, Colin R, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: BMJ Quality & Safety, 31(3), 179. BMJ Publishing Group
Morrow, R L, Mintzes, B, Souverein, P C, De Bruin, M L, Roughead, E E, Lexchin, J, Kemp-Casey, A, Puil, L, Sketris, I, Mangin, D, Hallgreen, C E, Pearson, S-A, Lopert, R, Bero, L, Ofori-Asenso, R, Gnjidic, D, Sarpatwari, A, Perry, L T & Dormuth, C R 2022, ' Influence of drug safety advisories on drug utilisation : an international interrupted time series and meta-analysis ', BMJ quality & safety, vol. 31, no. 3, pp. 179–190 . https://doi.org/10.1136/bmjqs-2021-013910

ObjectiveTo evaluate the association between regulatory drug safety advisories and changes in drug utilisation.DesignWe conducted controlled, interrupted times series analyses with administrative prescription claims data to estimate changes in drug u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a556a66cc6ce0f2badbc34efea94cd74
https://hdl.handle.net/11541.2/31074

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.